6/16/2022 Vaccine effectiveness of BNT162b2 against Delta and Omicron variants in adolescents Buchan SA, Nguyen L, Wilson SE, Kitchen SA, Kwong JC. Pediatrics. 2022; Jun 16 [Epub ahead of print]. DOI: https://doi.org/10.1542/peds.2022-057634
4/27/2022 Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance Nasreen S, Calzavara A, Buchan SA, Thampi N, Johnson C, Wilson SE, Kwong JC; on behalf of the Canadian Immunization Research Network CIRN Provincial Collaborative Network PCN Ontario investigators. Vaccine. 2022; 40(24):3305-12. Epub 2022 Apr 27. DOI: https://doi.org/10.1016/j.vaccine.2022.04.065
12/17/2021 Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study Nasreen S, Calzavara AJ, Sundaram ME, MacDonald SE, Righolt CH, Pai M, Field TS, Zhou LW, Wilson SE, Kwong JC. BMJ Open. 2021; 11(12):e052019. Epub 2021 Dec 17. DOI: https://doi.org/10.1136/bmjopen-2021-052019